Studying the genetic code of a lung infection
Part of Infections, Lungs & breathing clinical trials.
This study looks at samples from people who have a lung infection called PCP (a type of pneumonia). The goal is to learn more about the germ that causes it, which might lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with PCP (a lung infection) from a routine respiratory test
- Your test result shows a certain level of the infection (more than 50 copies per 10 microliters)
- You have not opted out of being included in UK medical research
- The study uses a sample from your regular test, so no extra procedures are needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to diagnose pneumocystis, a lung infection that can affect people with weakened immune systems. It may help find the infection faster and more accurately using samples taken from your lungs.
This study uses a powerful genetic test (next-generation sequencing) to find the cause of respiratory infections when standard tests fail. It may help identify hard-to-detect viruses, bacteria, or fungi in your lung or airway samples.
This research study examines proteins in fluid collected from your lungs during a breathing tube procedure (bronchoscopy) to better understand pneumonia. By studying these proteins, researchers hope to improve how doctors diagnose and treat lung infections.
This trial studies whether a more detailed genetic test of lung fluids can find the exact cause of pneumonia in people whose first treatment isn't working, and help doctors choose a more effective treatment sooner.
This study looks at the fluid around the lungs (pleural fluid) to understand infections that cause it. It aims to find better ways to treat these infections by studying the germs in the fluid.
This study looks at how certain blood cells react in people with lung conditions like asthma, COPD, pneumonia, or COVID-19. By analyzing a blood sample, researchers hope to learn more about the immune system's role in these diseases, which could lead to better treatments.
Hear when a new Pneumocystis Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.